100 related articles for article (PubMed ID: 32843568)
1. Persistent IL-2 Receptor Signaling by IL-2/CD25 Fusion Protein Controls Diabetes in NOD Mice by Multiple Mechanisms.
Ward NC; Lui JB; Hernandez R; Yu L; Struthers M; Xie J; Santos Savio A; Dwyer CJ; Hsiung S; Yu A; Malek TR
Diabetes; 2020 Nov; 69(11):2400-2413. PubMed ID: 32843568
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy With Low-Dose IL-2/CD25 Prevents β-Cell Dysfunction and Dysglycemia in Prediabetic NOD Mice.
Qureshi FM; Panzer JK; Põder J; Malek TR; Caicedo A
Diabetes; 2023 Jun; 72(6):769-780. PubMed ID: 36939730
[TBL] [Abstract][Full Text] [Related]
3. CD25-T
Solomon I; Amann M; Goubier A; Arce Vargas F; Zervas D; Qing C; Henry JY; Ghorani E; Akarca AU; Marafioti T; Śledzińska A; Werner Sunderland M; Franz Demane D; Clancy JR; Georgiou A; Salimu J; Merchiers P; Brown MA; Flury R; Eckmann J; Murgia C; Sam J; Jacobsen B; Marrer-Berger E; Boetsch C; Belli S; Leibrock L; Benz J; Koll H; Sutmuller R; Peggs KS; Quezada SA
Nat Cancer; 2020 Dec; 1(12):1153-1166. PubMed ID: 33644766
[TBL] [Abstract][Full Text] [Related]
4. Promoting Immune Regulation in Type 1 Diabetes Using Low-Dose Interleukin-2.
Dwyer CJ; Ward NC; Pugliese A; Malek TR
Curr Diab Rep; 2016 Jun; 16(6):46. PubMed ID: 27076179
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-2-induced skin inflammation.
Sommer C; Cohen JN; Dehmel S; Neuhaus V; Schaudien D; Braun A; Sewald K; Rosenblum MD
Eur J Immunol; 2024 Apr; 54(4):e2350580. PubMed ID: 38430129
[TBL] [Abstract][Full Text] [Related]
6. Distinct use of super-enhancer elements controls cell type-specific CD25 transcription and function.
Spolski R; Li P; Chandra V; Shin B; Goel S; Sakamoto K; Liu C; Oh J; Ren M; Enomoto Y; West EE; Christensen SM; Wan ECK; Ge M; Lin JX; Yan B; Kazemian M; Yu ZX; Nagao K; Vijayanand P; Rothenberg EV; Leonard WJ
Sci Immunol; 2023 Nov; 8(89):eadi8217. PubMed ID: 37922339
[TBL] [Abstract][Full Text] [Related]
7. Multivalent, asymmetric IL-2-Fc fusions show enhanced selectivity for regulatory T cells.
Orcutt-Jahns BT; Emmel PC; Snyder EM; Taylor SD; Meyer AS
Sci Signal; 2023 Oct; 16(807):eadg0699. PubMed ID: 37847758
[TBL] [Abstract][Full Text] [Related]
8. Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protection.
VanDyke D; Iglesias M; Tomala J; Young A; Smith J; Perry JA; Gebara E; Cross AR; Cheung LS; Dykema AG; Orcutt-Jahns BT; Henclová T; Golias J; Balolong J; Tomasovic LM; Funda D; Meyer AS; Pardoll DM; Hester J; Issa F; Hunter CA; Anderson MS; Bluestone JA; Raimondi G; Spangler JB
Cell Rep; 2022 Oct; 41(3):111478. PubMed ID: 36261022
[TBL] [Abstract][Full Text] [Related]
9. Sustained IL-2R signaling of limited duration by high-dose mIL-2/mCD25 fusion protein amplifies tumor-reactive CD8
Hernandez R; Toomer KH; Põder J; Santos Savio A; Hsiung S; Malek TR
Cancer Immunol Immunother; 2021 Apr; 70(4):909-921. PubMed ID: 33037893
[TBL] [Abstract][Full Text] [Related]
10. An All-in-One Nanomedicine Consisting of CRISPR-Cas9 and an Autoantigen Peptide for Restoring Specific Immune Tolerance.
Luo YL; Liang LF; Gan YJ; Liu J; Zhang Y; Fan YN; Zhao G; Czarna A; Lu ZD; Du XJ; Shen S; Xu CF; Lian ZX; Wang J
ACS Appl Mater Interfaces; 2020 Oct; 12(43):48259-48271. PubMed ID: 33070614
[TBL] [Abstract][Full Text] [Related]
11. PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance.
Tan CL; Kuchroo JR; Sage PT; Liang D; Francisco LM; Buck J; Thaker YR; Zhang Q; McArdel SL; Juneja VR; Lee SJ; Lovitch SB; Lian C; Murphy GF; Blazar BR; Vignali DAA; Freeman GJ; Sharpe AH
J Exp Med; 2021 Jan; 218(1):. PubMed ID: 33045061
[TBL] [Abstract][Full Text] [Related]
12. Role of the PD-1/PD-L1 Dyad in the Maintenance of Pancreatic Immune Tolerance for Prevention of Type 1 Diabetes.
Falcone M; Fousteri G
Front Endocrinol (Lausanne); 2020; 11():569. PubMed ID: 32973682
[TBL] [Abstract][Full Text] [Related]
13. Tissue-Engineered Stromal Reticula to Study Lymph Node Fibroblastic Reticular Cells in Type I Diabetes.
Gonzalez Badillo F; Zisi Tegou F; Masina R; Wright S; Scully M; Harwell L; Lupp M; Postigo-Fernandez J; Creusot RJ; Tomei AA
Cell Mol Bioeng; 2020 Oct; 13(5):419-434. PubMed ID: 33184575
[TBL] [Abstract][Full Text] [Related]
14. Mouse IL-2/CD25 Fusion Protein Induces Regulatory T Cell Expansion and Immune Suppression in Preclinical Models of Systemic Lupus Erythematosus.
Xie JH; Zhang Y; Loubeau M; Mangan P; Heimrich E; Tovar C; Zhou X; Madia P; Doyle M; Dudhgaonkar S; Rudra A; Subramani S; Young J; Salter-Cid L; Malek TR; Struthers M
J Immunol; 2021 Jul; 207(1):34-43. PubMed ID: 34108258
[TBL] [Abstract][Full Text] [Related]
15. Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis.
Buitrago-Molina LE; Pietrek J; Noyan F; Schlue J; Manns MP; Wedemeyer H; Hardtke-Wolenski M; Jaeckel E
J Autoimmun; 2021 Feb; 117():102591. PubMed ID: 33387980
[TBL] [Abstract][Full Text] [Related]
16. Acute Lipopolysaccharide-Induced Inflammation Lowers IL-2R Signaling and the Proliferative Potential of Regulatory T Cells.
Hsiung S; Moro A; Ban Y; Chen X; Savio AS; Hernandez R; Malek TR
Immunohorizons; 2020 Dec; 4(12):809-824. PubMed ID: 33334814
[TBL] [Abstract][Full Text] [Related]
17. Sequential immunotherapy: towards cures for autoimmunity.
Ramírez-Valle F; Maranville JC; Roy S; Plenge RM
Nat Rev Drug Discov; 2024 Jun; ():. PubMed ID: 38839912
[TBL] [Abstract][Full Text] [Related]
18. Refined protocol for newly onset identification in non-obese diabetic mice: an animal-friendly, cost-effective, and efficient alternative.
Liao CC; Hsieh CC; Shia WC; Chou MY; Huang CC; Lin JH; Lee SH; Sung HH
Lab Anim Res; 2024 Apr; 40(1):16. PubMed ID: 38649958
[TBL] [Abstract][Full Text] [Related]
19. Tipping the balance in autoimmunity: are regulatory t cells the cause, the cure, or both?
Hardtke-Wolenski M; Landwehr-Kenzel S
Mol Cell Pediatr; 2024 Mar; 11(1):3. PubMed ID: 38507159
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer.
Shouse AN; LaPorte KM; Malek TR
Immunity; 2024 Mar; 57(3):414-428. PubMed ID: 38479359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
